Patent 7435419 was granted and assigned to Beth Israel Deaconess Medical Center on October, 2008 by the United States Patent and Trademark Office.
Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia or a propensity to develop pre-eclampsia or eclampsia by detecting the levels of placental growth factor in a subject.